OPTIMIZERx Corp

OptimizeRx Corp., a healthcare technology company, has appointed Troy Sarich, a veteran pharmaceutical commercialization and AI expert, as a company advisor. Sarich, who brings nearly 30 years of experience, previously served as Chief Commercial Data Science Officer at Johnson & Johnson, where he advanced data-driven, AI-enabled healthcare. His expertise will support OptimizeRx's efforts to enhance its technology and data offerings for life sciences marketers. CEO Stephen Silvestro welcomed Sarich, citing his accomplishments at J&J and his alignment with the company's mission to deliver life-changing therapies to patients.

OptimizeRx Corp. has appointed Sarah Bast as its new Chief Marketing Officer. Bast brings more than two decades of pharmaceutical marketing experience, most recently serving as Executive Vice President, Investment Marketplace at Publicis Health Media, where she established partnerships and solution sets for major pharmaceutical brands. She will lead OptimizeRx's marketing strategy, brand positioning, and go-to-market initiatives, strengthening relationships with healthcare marketing agencies and in-house life sciences marketing teams. Bast joins the company as it expands its portfolio of technology and point-of-care solutions designed to simplify healthcare marketing and enable more meaningful engagement between life sciences brands, healthcare providers, and patients.

OptimizeRx has launched its patent-pending Natural Language Audience Builder, an AI-powered tool designed to be embedded within demand-side platforms and agency media planning platforms. The tool combines real-world evidence with proprietary data from OptimizeRx’s EHR network, enabling life sciences companies and agency marketers to create and manage custom healthcare provider audiences without code or analyst support. Marketers can view, rank, and filter matching HCP profile details including specialty, patient volumes, and prescribing behavior, and understand NPI-level reach across programmatic, social, EHR, and field force channels. The launch builds on OptimizeRx’s prior opening of programmatic access to its authenticated EHR inventory and expands its role as an infrastructure partner for life sciences manufacturers, agencies, and DSPs. NLAB will be available for platform integration from August 2026 and can be bundled with the integration of OptimizeRx’s authenticated point of care inventory.